DNA based diagnostics
Published by Guillaume May 16th, 2006 in General
deCODE genetics and Illumina are creating an alliance to provide DNA based diagnostics.
deCODE genetics (Nasdaq:DCGN) and Illumina, Inc. (Nasdaq:ILMN) today announced the formation of a strategic alliance under which the companies plan to co-develop and commercialize DNA-based diagnostic tests in several major disease areas. The alliance will employ Illumina’s platform for high-multiplex single-nucleotide polymorphism (SNP) genotyping to develop tests for gene variants deCODE has previously shown to have impact on the risk of a growing number of common diseases with major public health impact.
DNA based diagnostics
Published by Guillaume May 16th, 2006 in General deCODE genetics and Illumina are creating an alliance to provide DNA based diagnostics.
deCODE genetics (Nasdaq:DCGN) and Illumina, Inc. (Nasdaq:ILMN) today announced the formation of a strategic alliance under which the companies plan to co-develop and commercialize DNA-based diagnostic tests in several major disease areas. The alliance will employ Illumina’s platform for high-multiplex single-nucleotide polymorphism (SNP) genotyping to develop tests for gene variants deCODE has previously shown to have impact on the risk of a growing number of common diseases with major public health impact.
No Responses to “DNA based diagnostics”
Please Wait
Leave a Reply
You must log in to post a comment.